Genotype influences in vivo dopamine transporter availability in human striatum.
paper
Cited
Public
Unavailable
- Authors
- Heinz, A; Goldman, D; Jones, D W; Palmour, R; Hommer, D; Gorey, J G; Lee, K S; Linnoila, M; Weinberger, D R
- Year
- 2000
- Journal
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- PMID
- 10649826
- DOI
- 10.1016/S0893-133X(99)00099-8
In vivo availability of striatal dopamine transporter (DAT) protein has been reported to be reduced among alcoholics, and allelic variation of the DAT gene (SLC6A3) has been associated with severity of alcohol withdrawal. We examined the VNTR polymorphism of the 3' untranslated region of SLC6A3 and DAT protein availability in 14 abstinent alcoholics and 11 control subjects. Single photon emission computed tomography (SPECT) and plasma levels of the radioligand [I-123]beta-CIT were used to quantify DAT protein availability. Individuals with the 9-repeat/10-repeat genotype had a mean 22% reduction of DAT protein availability in putamen compared with 10-repeat homozygous individuals (t = 2.14, df = 23, p < .05). Consistent with earlier studies, alcoholism, per se, was not significantly associated with either DAT availability or DAT genotype. These findings suggest that the VNTR polymorphism of the DAT gene effects translation of the DAT protein. This effect may explain a variety of clinical associations that have been reported with this polymorphism.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The functional minisatellite at the 3'-UTR of SLC6A3/DAT1 and dementia spectrum disorders: an association study in a population of Central Italy. | Torbidoni-Baldassari B et al. | β | 2026 | β |
| Genetic association of SLC6A3 (dopamine transporter) gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and meta-analysis. | Vogiatzoglou AV et al. | β | 2024 | β |
| Association between opioid and dopamine receptor gene polymorphisms OPRM1 rs1799971, DAT VNTR 9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analysis. | Suresh N et al. | β | 2023 | β |
| Association of <i>SLC6A3</i> variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia. | Kogure M et al. | β | 2023 | β |
| Candidate gene-environment interactions in substance abuse: A systematic review. | Jiang Z et al. | β | 2023 | β |
| Neuroimaging genetics approaches to identify new biomarkers for the early diagnosis of autism spectrum disorder. | Nisar S et al. | β | 2023 | β |
| The molecular genetic basis of creativity: a mini review and perspectives. | Zhang S et al. | β | 2023 | β |
| Childhood trauma and genetic variation in the <i>DAT</i> 40-bp VNTR contribute to HIV-associated neurocognitive disorders. | Roomaney AA et al. | β | 2022 | β |
| Disordered eating in early childhood: DRD4 and DAT1 gene polymorphisms and quality of mother-child interaction. | Pascale E et al. | β | 2022 | β |
| Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial. | Schacht JP et al. | β | 2022 | β |
| <i>ANKK1</i> and <i>TH</i> gene variants in combination with paternal maltreatment increase susceptibility to both cognitive and attentive impulsivity. | Palumbo S et al. | β | 2022 | β |
| <i>SLC6A3</i>, <i>HTR2C</i> and <i>HTR6</i> Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism. | Nedic Erjavec G et al. | β | 2022 | β |
| Testosterone eliminates strategic prosocial behavior through impacting choice consistency in healthy males | Kutlikova HH et al. | β | 2022 | β |
| A causal role of estradiol in human reinforcement learning. | Veselic S et al. | β | 2021 | β |
| Bingeing on High-Fat Food Enhances Evoked Dopamine Release and Reduces Dopamine Uptake in the Nucleus Accumbens. | Jones SR et al. | β | 2021 | β |
| DAT1 and Its Psychological Correlates in Children with Avoidant/Restrictive Food Intake Disorder: A Cross-Sectional Pilot Study. | Cimino S et al. | β | 2021 | β |
| Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease. | Sheng J et al. | β | 2021 | β |
| The 10-Repeat 3'-UTR VNTR Polymorphism in the <i>SLC6A3</i> Gene May Confer Protection Against Parkinson's Disease: A Meta-analysis. | Zeng Q et al. | β | 2021 | β |
| Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. | Myszczynska MA et al. | β | 2020 | β |
| Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease. | du Plessis S et al. | β | 2020 | β |
| Cumulative Dopamine Genetic Score predicts behavioral and electrophysiological correlates of response inhibition via interactions with task demand. | Enge S et al. | β | 2020 | β |
| Dopamine Related Genes Differentially Affect Declarative Long-Term Memory in Healthy Humans. | Leukel C et al. | β | 2020 | β |
| Emotional-Behavioral Regulation, Temperament and Parent-Child Interactions Are Associated with Dopamine Transporter Allelic Polymorphism in Early Childhood: A Pilot Study. | Cimino S et al. | β | 2020 | β |
| Exogenous testosterone increases status-seeking motivation in men with unstable low social status. | Losecaat Vermeer AB et al. | β | 2020 | β |
| Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. | Anton RF et al. | β | 2020 | β |
| Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case-control study. | Culej J et al. | β | 2020 | β |
| DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease. | Purcaro C et al. | β | 2019 | β |
| Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. | Hansson AC et al. | β | 2019 | β |
| Dopamine and Working Memory: Genetic Variation, Stress and Implications for Mental Health. | Klaus K et al. | β | 2019 | β |
| Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. | Amato D et al. | β | 2019 | β |
| Interactive effects of dopamine transporter genotype and aging on resting-state functional networks. | Baeuchl C et al. | β | 2019 | β |
| Inter-individual maternal care received and genotype interactions affect dopaminergic phenotypes in female rat offspring. | Lauby SC et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Novel approaches to alcohol rehabilitation: Modification of stress-responsive brain regions through environmental enrichment. | Pang TY et al. | β | 2019 | β |
| Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. | Kampangkaew JP et al. | β | 2019 | β |
| The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. | Schacht JP et al. | β | 2019 | β |
| Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System. | Torrisi SA et al. | β | 2019 | β |
| The Translational Potential of Neuroimaging Genomic Analyses To Diagnosis And Treatment In The Mental Disorders. | Chen J et al. | β | 2019 | β |
| Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies. | Ashok AH et al. | β | 2019 | β |
| A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity. | Schuckit MA | β | 2018 | β |
| Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective <sup>123</sup>I-FP-CIT SPECT imaging genetic study. | Hellwig S et al. | β | 2018 | β |
| Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects. | Rampino A et al. | β | 2018 | β |
| COMT and DAT1 polymorphisms moderate the indirect effect of parenting behavior on youth ADHD symptoms through neurocognitive functioning. | Morgan JE et al. | β | 2018 | β |
| DAT1-Genotype and Menstrual Cycle, but Not Hormonal Contraception, Modulate Reinforcement Learning: Preliminary Evidence. | Jakob K et al. | β | 2018 | β |
| Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. | Schacht JP et al. | β | 2018 | β |
| Dopamine Transporter Gene Methylation is Associated with Nucleus Accumbens Activation During Reward Processing in Healthy but not Alcohol-Dependent Individuals. | Muench C et al. | β | 2018 | β |
| Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease. | LΓΆhle M et al. | β | 2018 | β |
| Gene x environment interactions in conduct disorder: Implications for future treatments. | Holz NE et al. | β | 2018 | β |
| Interaction between striatal volume and DAT1 polymorphism predicts working memory development during adolescence. | Nemmi F et al. | β | 2018 | β |
| Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity. | Adriani W et al. | β | 2018 | β |
| Testing bidirectional relationships between alcohol use and depressive symptoms: What is the role of the serotonin transporter gene? | Otten R et al. | β | 2018 | β |
| The Catechol-O-Methyltransferase and Dopamine Transporter Genes Moderated the Impact of Peer Relationships on Adolescent Depressive Symptoms: A Gene-Gene-Environment Study. | Cao Y et al. | β | 2018 | β |
| The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users. | Batalla A et al. | β | 2018 | β |
| Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension. | Kim WT et al. | β | 2017 | β |
| Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake. | Addolorato G et al. | β | 2017 | β |
| Dopamine transporter gene polymorphism in children with ADHD: A pilot study in Indonesian samples. | Wiguna T et al. | β | 2017 | β |
| Genetically-Driven Enhancement of Dopaminergic Transmission Affects Moral Acceptability in Females but Not in Males: A Pilot Study. | Pellegrini S et al. | β | 2017 | β |
| Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential. | Bogdan R et al. | β | 2017 | β |
| Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers. | Weerts EM et al. | β | 2017 | β |
| Individual differences in EEG correlates of recognition memory due to DAT polymorphisms. | Medrano P et al. | β | 2017 | β |
| Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: Studies with positron emission tomography. | Volkow ND et al. | β | 2017 | β |
| Neuroimaging genomics in psychiatry-a translational approach. | Mufford MS et al. | β | 2017 | β |
| Obesity: Current and potential pharmacotherapeutics and targets. | Narayanaswami V et al. | β | 2017 | β |
| Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. | Eisenstein SA et al. | β | 2017 | β |
| Task demands, tDCS intensity, and the COMT val<sup>158</sup>met polymorphism impact tDCS-linked working memory training gains. | Stephens JA et al. | β | 2017 | β |
| The association of insertions/deletions (INDELs) and variable number tandem repeats (VNTRs) with obesity and its related traits and complications. | Say YH et al. | β | 2017 | β |
| The neural underpinnings of cognitive flexibility and their disruption in psychotic illness. | Waltz JA | β | 2017 | β |
| A Genetic Polymorphism of the Human Dopamine Transporter Determines the Impact of Sleep Deprivation on Brain Responses to Rewards and Punishments. | Greer SM et al. | β | 2016 | β |
| Dopamine and the Creative Mind: Individual Differences in Creativity Are Predicted by Interactions between Dopamine Genes DAT and COMT. | Zabelina DL et al. | β | 2016 | β |
| Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole. | MacDonald HJ et al. | β | 2016 | β |
| Dopaminergic Modulation of Cognitive Preparation for Overt Reading: Evidence from the Study of Genetic Polymorphisms. | Arnold C et al. | β | 2016 | β |
| Effects of Antipsychotic Treatment on Depressive Symptoms With Respect to Genetic Polymorphisms Related to Dopaminergic and Serotoninergic Neurotransmission in Schizophrenia Patients. | Misiak B et al. | β | 2016 | β |
| Genetic substrates of psychosis in patients with Parkinson's disease: A critical review. | Lenka A et al. | β | 2016 | β |
| Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function. | Singer BF et al. | β | 2016 | β |
| Meta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations. | Ma Y et al. | β | 2016 | β |
| Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence. | Ma Y et al. | β | 2016 | β |
| Neural vulnerability factors that increase risk for future weight gain. | Stice E et al. | β | 2016 | β |
| Teacher-student relationships and adolescent behavioral engagement and rule-breaking behavior: The moderating role of dopaminergic genes. | De Laet S et al. | β | 2016 | β |
| Transactional Links Between Teacher-Student Relationships and Adolescent Rule-Breaking Behavior and Behavioral School Engagement: Moderating Role of a Dopaminergic Genetic Profile Score. | De Laet S et al. | β | 2016 | β |
| A genetic-demographic approach reveals a gender-specific association of SLC6A3/DAT1 40Β bp-VNTR with life-expectancy. | Hadi F et al. | β | 2015 | β |
| An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults. | Tong JH et al. | β | 2015 | β |
| A review of potential pharmacogenetic effects on catecholamine responses. | Ounissi M et al. | β | 2015 | β |
| Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil. | Vasconcelos AC et al. | β | 2015 | β |
| Commonly-occurring polymorphisms in the COMT, DRD1 and DRD2 genes influence different aspects of motor sequence learning in humans. | Baetu I et al. | β | 2015 | β |
| Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype. | FernΓ‘ndez-JaΓ©n A et al. | β | 2015 | β |
| Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. | Sami MB et al. | β | 2015 | β |
| Genes of the dopaminergic system selectively modulate top-down but not bottom-up attention. | Schneider KK et al. | β | 2015 | β |
| How Imaging Glutamate, Ξ³-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal. | Hillmer AT et al. | β | 2015 | β |
| Indirect association of DAT1 genotype with executive function through white matter volume in orbitofrontal cortex. | Chung T et al. | β | 2015 | β |
| Individual differences in approach-avoidance aptitude: some clues from research on Parkinson's disease. | Costa A et al. | β | 2015 | β |
| Mesocorticolimbic dopamine functioning in primary psychopathy:Β A source of within-group heterogeneity. | Yildirim BO et al. | β | 2015 | β |
| Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity. | Stanfill AG et al. | β | 2015 | β |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | β | 2015 | β |
| Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI. | Yokum S et al. | β | 2015 | β |
| Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function. | Gordon EM et al. | β | 2015 | β |
| Underlying Mechanisms of Gene-Environment Interactions in Externalizing Behavior: A Systematic Review and Search for Theoretical Mechanisms. | Weeland J et al. | β | 2015 | β |
| ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. | Kollins SH et al. | β | 2014 | β |
| Adolescent brain maturation and smoking: what we know and where we're headed. | Lydon DM et al. | β | 2014 | β |
| A review of multivariate analyses in imaging genetics. | Liu J et al. | β | 2014 | β |
| A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infection. | Koutsilieri E et al. | β | 2014 | β |
| Association between amygdala reactivity and a dopamine transporter gene polymorphism. | Bergman O et al. | β | 2014 | β |
| Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems. | Hall FS et al. | β | 2014 | β |
| Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. | Pearson-Fuhrhop KM et al. | β | 2014 | β |
| Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. | Holst SC et al. | β | 2014 | β |
| Dopamine system genes are associated with orienting bias among healthy individuals. | Zozulinsky P et al. | β | 2014 | β |
| Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates. | Rajala AZ et al. | β | 2014 | β |
| Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder. | Stein MA et al. | β | 2014 | β |
| Dopamine transporter genotype is associated with a lateralized resistance to distraction during attention selection. | Newman DP et al. | β | 2014 | β |
| Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease. | Habak C et al. | β | 2014 | β |
| Effects and mechanisms of working memory training: a review. | von Bastian CC et al. | β | 2014 | β |
| Enhanced prepulse inhibition and low sensitivity to a dopamine agonist in HESR1 knockout mice. | Kanno K et al. | β | 2014 | β |
| Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. | Faraone SV et al. | β | 2014 | β |
| Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. | Valomon A et al. | β | 2014 | β |
| Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load. | Smith CT et al. | β | 2014 | β |
| Imaging studies on dopamine transporter and depression: a review of literature and suggestions for future research. | Camardese G et al. | β | 2014 | β |
| Molecular imaging in alcohol dependence. | Ravan S et al. | β | 2014 | β |
| Polymorphisms of COMT Val158Met and DAT1 3'-UTR VNTR in illicit drug use and drug-related psychiatric disorders. | Chen CK et al. | β | 2014 | β |
| Social disadvantage, genetic sensitivity, and children's telomere length. | Mitchell C et al. | β | 2014 | β |
| The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. | Cagniard B et al. | β | 2014 | β |
| The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI. | Wagner AK et al. | β | 2014 | β |
| Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory. | Li SC et al. | β | 2013 | β |
| Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. | Greenwood TA et al. | β | 2013 | β |
| Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females. | Heitland I et al. | β | 2013 | β |
| Child dopamine active transporter 1 genotype and parenting: evidence for evocative gene-environment correlations. | Hayden EP et al. | β | 2013 | β |
| DAT1 polymorphism determines L-DOPA effects on learning about others' prosociality. | Eisenegger C et al. | β | 2013 | β |
| DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing. | Taurisano P et al. | β | 2013 | β |
| Dopamine and training-related working-memory improvement. | BΓ€ckman L et al. | β | 2013 | β |
| Dopamine, norepinephrine, and the management of sensorimotor bindings: individual differences in updating of stimulus-response episodes are predicted by DAT1, but not DBH5'-ins/del. | Colzato LS et al. | β | 2013 | β |
| Dopaminergic control of cognitive flexibility in humans and animals. | Klanker M et al. | β | 2013 | β |
| Dopaminergic gene polymorphisms affect long-term forgetting in old age: further support for the magnification hypothesis. | Papenberg G et al. | β | 2013 | β |
| Dopamine transporter genotype dependent effects of apomorphine on cold pain tolerance in healthy volunteers. | Treister R et al. | β | 2013 | β |
| Effects of aging and dopamine genotypes on the emergence of explicit memory during sequence learning. | Schuck NW et al. | β | 2013 | β |
| Epistasis effects of dopamine genes on interval timing and reward magnitude in humans. | BalcΔ± F et al. | β | 2013 | β |
| Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients. | Gordiev M et al. | β | 2013 | β |
| Genetics of impulse control disorders in Parkinson's disease. | Cormier F et al. | β | 2013 | β |
| Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa. | Pearson-Fuhrhop KM et al. | β | 2013 | β |
| Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals. | Horn A et al. | β | 2013 | β |
| Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features. | Gervasini G et al. | β | 2013 | β |
| Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. | Schacht JP et al. | β | 2013 | β |
| Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function. | Pauli A et al. | β | 2013 | β |
| Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: a structural equation modeling approach. | Li JJ et al. | β | 2013 | β |
| Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction. | Ceravolo R et al. | β | 2013 | β |
| MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder. | Schweren LJ et al. | β | 2013 | β |
| Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial. | Pasini A et al. | β | 2013 | β |
| Neurogenetics of depression: a focus on reward processing and stress sensitivity. | Bogdan R et al. | β | 2013 | β |
| Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors. | Yamamoto DJ et al. | β | 2013 | β |
| The association of a novel haplotype in the dopamine transporter with preschool age posttraumatic stress disorder. | Drury SS et al. | β | 2013 | β |
| The dopamine transporter haplotype and reward-related striatal responses in adult ADHD. | Hoogman M et al. | β | 2013 | β |
| Additive effects of the dopamine D2 receptor and dopamine transporter genes on the error-related negativity in young children. | Meyer A et al. | β | 2012 | β |
| DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART). | Mata R et al. | β | 2012 | β |
| Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram. | Warwick JM et al. | β | 2012 | β |
| Dopamine transporter genotype predicts attentional asymmetry in healthy adults. | Newman DP et al. | β | 2012 | β |
| Dopamine transporter polymorphisms affect social approach-avoidance tendencies. | Enter D et al. | β | 2012 | β |
| Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state. | Gordon EM et al. | β | 2012 | β |
| Effects of COMT polymorphisms on brain function and behavior in health and disease. | Witte AV et al. | β | 2012 | β |
| Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating- and personality-related psychopathology. | Thaler L et al. | β | 2012 | β |
| From disordered eating to addiction: the "food drug" in bulimia nervosa. | Umberg EN et al. | β | 2012 | β |
| Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans. | Heitland I et al. | β | 2012 | β |
| Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. | Sweitzer MM et al. | β | 2012 | β |
| Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis. | Li JJ et al. | β | 2012 | β |
| Linking neurogenetics and individual differences in language learning: the dopamine hypothesis. | Wong PC et al. | β | 2012 | β |
| Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. | Stice E et al. | β | 2012 | β |
| Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. | Jarcho JM et al. | β | 2012 | β |
| Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of Ξ΄-9-tetrahydrocannabinol on midbrain and striatal function. | Bhattacharyya S et al. | β | 2012 | β |
| The androgen receptor facilitates inhibition of human dopamine transporter (DAT1) reporter gene expression by HESR1 and HESR2 via the variable number of tandem repeats. | Kanno K et al. | β | 2012 | β |
| The future of fMRI and genetics research. | Meyer-Lindenberg A | β | 2012 | β |
| The role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disorders. | Montag C et al. | β | 2012 | β |
| Toward a mechanistic understanding of how variability in neurobiology shapes individual differences in behavior. | Bogdan R et al. | β | 2012 | β |
| A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure. | Kordas K et al. | β | 2011 | β |
| Alcohol and the human brain: a systematic review of different neuroimaging methods. | BΓΌhler M et al. | β | 2011 | β |
| A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. | Lonsdorf TB et al. | β | 2011 | β |
| Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. | Hahn T et al. | β | 2011 | β |
| Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats. | Kanno K et al. | β | 2011 | β |
| Disentangling the roles of approach, activation and valence in instrumental and pavlovian responding. | Huys QJ et al. | β | 2011 | β |
| Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. | Franklin TR et al. | β | 2011 | β |
| Dopamine transporter genotype predicts implicit sequence learning. | Simon JR et al. | β | 2011 | β |
| Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls. | Shook D et al. | β | 2011 | β |
| Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers. | Blanchard MM et al. | β | 2011 | β |
| Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction. | Raczka KA et al. | β | 2011 | β |
| Genetically determined dopamine availability predicts disposition for depression. | Felten A et al. | β | 2011 | β |
| Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls. | Xu M et al. | β | 2011 | β |
| Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery. | Alexander N et al. | β | 2011 | β |
| Genotype and ancestry modulate brain's DAT availability in healthy humans. | Shumay E et al. | β | 2011 | β |
| Human cognitive flexibility depends on dopamine D2 receptor signaling. | van Holstein M et al. | β | 2011 | β |
| Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms. | Lahey BB et al. | β | 2011 | β |
| Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. | Nikolova YS et al. | β | 2011 | β |
| Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. | Kebir O et al. | β | 2011 | β |
| Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. | Costa A et al. | β | 2011 | β |
| Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks. | Brown AB et al. | β | 2011 | β |
| The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-a meta-analysis. | Du Y et al. | β | 2011 | β |
| The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. | Millar A et al. | β | 2011 | β |
| Variation in genes involved in dopamine clearance influence the startle response in older adults. | Armbruster D et al. | β | 2011 | β |
| Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. | Nemoda Z et al. | β | 2010 | β |
| Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. | Brousse G et al. | β | 2010 | β |
| Depression and the role of genes involved in dopamine metabolism and signalling. | Opmeer EM et al. | β | 2010 | β |
| Dopamine and binge eating behaviors. | Bello NT et al. | β | 2010 | β |
| Dopaminergic genotype influences spatial bias in healthy adults. | Greene CM et al. | β | 2010 | β |
| Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. | BΓ©dard AC et al. | β | 2010 | β |
| Dopamine transporter regulates the enhancement of novelty processing by a negative emotional context. | Garcia-Garcia M et al. | β | 2010 | β |
| Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. | Dresler T et al. | β | 2010 | β |
| DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. | Turic D et al. | β | 2010 | β |
| Early institutionalization: neurobiological consequences and genetic modifiers. | Sheridan M et al. | β | 2010 | β |
| Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder. | Brown AB et al. | β | 2010 | β |
| Genetic association studies of performance monitoring and learning from feedback: the role of dopamine and serotonin. | Ullsperger M | β | 2010 | β |
| Genetic determinants of time perception mediated by the serotonergic system. | Sysoeva OV et al. | β | 2010 | β |
| Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. | SΓ‘iz PA et al. | β | 2010 | β |
| Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity. | Shumay E et al. | β | 2010 | β |
| Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics. | Reese J et al. | β | 2010 | β |
| Imaging genetics--days of future past. | Bigos KL et al. | β | 2010 | β |
| Imaging receptor changes in human drug abusers. | Cosgrove KP | β | 2010 | β |
| Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. | Willeit M et al. | β | 2010 | β |
| Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. | Anghelescu I et al. | β | 2010 | β |
| Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. | Yeh YW et al. | β | 2010 | β |
| Neural markers of genetic vulnerability to drug addiction. | MΓΌller DJ et al. | β | 2010 | β |
| Neural response to working memory load varies by dopamine transporter genotype in children. | Stollstorff M et al. | β | 2010 | β |
| Neurobehavioral evidence for changes in dopamine system activity during adolescence. | Wahlstrom D et al. | β | 2010 | β |
| No influence of SLC6A3 40 base VNTR polymorphism on the response to risperidone. | Pae CU et al. | β | 2010 | β |
| Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. | Xu M et al. | β | 2010 | β |
| Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging. | Aarts E et al. | β | 2010 | β |
| The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors. | Guo G et al. | β | 2010 | β |
| The dopamine transporter gene (DAT1) polymorphism is associated with premature ejaculation. | Santtila P et al. | β | 2010 | β |
| The role of the dopamine transporter DAT1 genotype on the neural correlates of cognitive flexibility. | Garcia-Garcia M et al. | β | 2010 | β |
| Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD. | Althaus M et al. | β | 2010 | β |
| An interaction between DAT1 and having an alcoholic father predicts serious alcohol problems in a sample of males. | Vaske J et al. | β | 2009 | β |
| Association between harmful alcohol consumption behavior and dopamine transporter (DAT1) gene polymorphisms in a male Finnish population. | Lind PA et al. | β | 2009 | β |
| Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. | Filonzi L et al. | β | 2009 | β |
| Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. | Kebir O et al. | β | 2009 | β |
| Candidate gene studies of ADHD: a meta-analytic review. | Gizer IR et al. | β | 2009 | β |
| DAT genotype modulates brain and behavioral responses elicited by cigarette cues. | Franklin TR et al. | β | 2009 | β |
| Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking. | Cosgrove KP et al. | β | 2009 | β |
| Dopamine genes and nicotine dependence in treatment-seeking and community smokers. | Bergen AW et al. | β | 2009 | β |
| Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations. | Bhaskar LV et al. | β | 2009 | β |
| Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen. | Scherk H et al. | β | 2009 | β |
| Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. | Prata DP et al. | β | 2009 | β |
| Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study. | Hersrud SL et al. | β | 2009 | β |
| Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. | Bertolino A et al. | β | 2009 | β |
| Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. | Forbes EE et al. | β | 2009 | β |
| Imaging genetics in ADHD: a focus on cognitive control. | Durston S et al. | β | 2009 | β |
| Influence of SLC6A3 and COMT variation on neural activation during response inhibition. | Congdon E et al. | β | 2009 | β |
| Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. | Sieminska A et al. | β | 2009 | β |
| Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. | Chambers CD et al. | β | 2009 | β |
| Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. | Haile CN et al. | β | 2009 | β |
| Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review. | van der Zwaluw CS et al. | β | 2009 | β |
| Reduced sensitivity to the locomotor-stimulant effects of cocaine is associated with increased sensitivity to its discriminative stimulus properties. | Klein DA et al. | β | 2009 | β |
| SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | Azzato EM et al. | β | 2009 | β |
| Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. | van de Giessen E et al. | β | 2009 | β |
| The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. | Yacubian J et al. | β | 2009 | β |
| The interaction between the dopamine transporter gene and age at onset in relation to tobacco and alcohol use among 19-year-olds. | Schmid B et al. | β | 2009 | β |
| The neurobiology of individual differences in complex behavioral traits. | Hariri AR | β | 2009 | β |
| The role of the dopamine transporter (DAT) in the development of PTSD in preschool children. | Drury SS et al. | β | 2009 | β |
| Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging? | Plomp E et al. | β | 2009 | β |
| Variation in dopamine genes influences responsivity of the human reward system. | Dreher JC et al. | β | 2009 | β |
| Verbal but not performance IQ is highly correlated to externalizing behavior in boys with ADHD carrying both DRD4 and DAT1 risk genotypes. | Kebir O et al. | β | 2009 | β |
| Working memory plasticity modulated by dopamine transporter genotype. | Brehmer Y et al. | β | 2009 | β |
| A gene-based evolutionary explanation for the association between criminal involvement and number of sex partners. | Beaver KM et al. | β | 2008 | β |
| A neurogenetic approach to impulsivity. | Congdon E et al. | β | 2008 | β |
| Case-control and within-family tests for an association between conduct disorder and DAT1. | Schulz-Heik RJ et al. | β | 2008 | β |
| Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. | Karama S et al. | β | 2008 | β |
| Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. | Durston S et al. | β | 2008 | β |
| Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. | Bertolino A et al. | β | 2008 | β |
| Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. | Laucht M et al. | β | 2008 | β |
| Molecular genetics of attention. | Bellgrove MA et al. | β | 2008 | β |
| Molecular genetics of monoamine transporters: relevance to brain disorders. | Haddley K et al. | β | 2008 | β |
| Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). | Kooij JS et al. | β | 2008 | β |
| Role of dopamine in the motivational and cognitive control of behavior. | Cools R | β | 2008 | β |
| Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD. | Bellgrove MA et al. | β | 2008 | β |
| SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. | Krause J | β | 2008 | β |
| The 3' part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependence. | Le Strat Y et al. | β | 2008 | β |
| Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system. | Walitza S et al. | β | 2008 | β |
| A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. | Yang B et al. | β | 2007 | β |
| A pharmacogenomic evaluation of migraine therapy. | Johnson MP et al. | β | 2007 | β |
| A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. | Genro JP et al. | β | 2007 | β |
| Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. | Guo G et al. | β | 2007 | β |
| Dopamine genes and pathological gambling in discordant sib-pairs. | da Silva Lobo DS et al. | β | 2007 | β |
| Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene. | Tarnok Z et al. | β | 2007 | β |
| Dopaminergic genotype biases spatial attention in healthy children. | Bellgrove MA et al. | β | 2007 | β |
| Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. | Joober R et al. | β | 2007 | β |
| Dopamine transporter, gender, and number of sexual partners among young adults. | Guo G et al. | β | 2007 | β |
| Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. | Zhang A et al. | β | 2007 | β |
| Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. | Nutt DJ et al. | β | 2007 | β |
| Food reinforcement and eating: a multilevel analysis. | Epstein LH et al. | β | 2007 | β |
| Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. | Epstein LH et al. | β | 2007 | β |
| Gene-gene interaction associated with neural reward sensitivity. | Yacubian J et al. | β | 2007 | β |
| Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study. | Ton TG et al. | β | 2007 | β |
| Genetics of dopamine and its contribution to cocaine addiction. | Haile CN et al. | β | 2007 | β |
| Hormonal and genetic influences on processing reward and social information. | CaldΓΊ X et al. | β | 2007 | β |
| Imaging the neurochemistry of alcohol and substance abuse. | Martinez D et al. | β | 2007 | β |
| Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. | CaldΓΊ X et al. | β | 2007 | β |
| Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. | HΓΌnnerkopf R et al. | β | 2007 | β |
| Potential genetic causes of heterogeneity of treatment effects. | Goldstein DB et al. | β | 2007 | β |
| Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study. | Reimold M et al. | β | 2007 | β |
| Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. | Brookes KJ et al. | β | 2007 | β |
| Rodent models: utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD). | Mill J | β | 2007 | β |
| Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. | Wagner AK et al. | β | 2007 | β |
| The functional impact of SLC6 transporter genetic variation. | Hahn MK et al. | β | 2007 | β |
| Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. | Segman RH et al. | β | 2007 | β |
| 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study. | Kelada SN et al. | β | 2006 | β |
| Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. | Bertolino A et al. | β | 2006 | β |
| ADHD and the dopamine transporter: are there reasons to pay attention? | Mazei-Robinson MS et al. | β | 2006 | β |
| A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. | Cevoli S et al. | β | 2006 | β |
| An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. | Timberlake DS et al. | β | 2006 | β |
| Association study of 5'-UTR polymorphisms of the human dopamine transporter gene with manic depression. | StΓΆber G et al. | β | 2006 | β |
| Attention deficit hyperactivity disorder. | Kuntsi J et al. | β | 2006 | β |
| Food reinforcement. | Epstein LH et al. | β | 2006 | β |
| Functional polymorphisms in dopamine and serotonin pathway genes. | D'Souza UM et al. | β | 2006 | β |
| Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. | Brody AL et al. | β | 2006 | β |
| Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. | Carrasco X et al. | β | 2006 | β |
| [Heritability and candidate genes in tobacco use]. | Hamdani N et al. | β | 2006 | β |
| Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system. | Fuke S et al. | β | 2006 | β |
| Human genetics and pharmacology of neurotransmitter transporters. | Lin Z et al. | β | 2006 | β |
| Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. | Greenwood TA et al. | β | 2006 | β |
| Lack of association between polymorphisms of the dopamine receptor D4 and dopamine transporter genes and personality traits in a Korean population. | Kim SJ et al. | β | 2006 | β |
| No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children. | Cheuk DK et al. | β | 2006 | β |
| Obesity is associated with genetic variants that alter dopamine availability. | Need AC et al. | β | 2006 | β |
| Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. | Hurd YL | β | 2006 | β |
| Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. | Krause J et al. | β | 2006 | β |
| The current status of association studies in obsessive-compulsive disorder. | Hemmings SM et al. | β | 2006 | β |
| The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. | Schott BH et al. | β | 2006 | β |
| The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. | Kim JW et al. | β | 2006 | β |
| The genetics of attention deficit hyperactivity disorder. | Waldman ID et al. | β | 2006 | β |
| The genetics of nicotine dependence: relationship to pancreatic cancer. | MacLeod SL et al. | β | 2006 | β |
| Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients. | Gerra G et al. | β | 2005 | β |
| Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. | Bellgrove MA et al. | β | 2005 | β |
| Association of the dopamine transporter gene with alcoholism. | KΓΆhnke MD et al. | β | 2005 | β |
| Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. | Polanczyk G et al. | β | 2005 | β |
| Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. | Szobot C et al. | β | 2005 | β |
| Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. | Durston S et al. | β | 2005 | β |
| Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. | Bellgrove MA et al. | β | 2005 | β |
| Dopamine transporter gene associated with diminished subjective response to amphetamine. | Lott DC et al. | β | 2005 | β |
| Dopamine transporter genotype and methylphenidate dose response in children with ADHD. | Stein MA et al. | β | 2005 | β |
| Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. | Kelada SN et al. | β | 2005 | β |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | β | 2005 | β |
| Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. | Caron L et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects. | Spraggs CF et al. | β | 2005 | β |
| Pharmacotherapy and pharmacogenetics of nicotine dependence. | Berrettini WH et al. | β | 2005 | β |
| Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. | Jucaite A et al. | β | 2005 | β |
| Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). | Feng Y et al. | β | 2005 | β |
| The dopamine transporter and attention-deficit/hyperactivity disorder. | Madras BK et al. | β | 2005 | β |
| The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches. | Congdon E et al. | β | 2005 | β |
| The genetics of attention deficit hyperactivity disorder. | Thapar A et al. | β | 2005 | β |
| The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. | Cheon KA et al. | β | 2005 | β |
| The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. | VanNess SH et al. | β | 2005 | β |
| Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). | Mill J et al. | β | 2005 | β |
| Treating tobacco dependence: state of the science and new directions. | Lerman C et al. | β | 2005 | β |
| Attention-Deficit Hyperactivity Disorder in the post-genomic era. | Asherson P et al. | β | 2004 | β |
| DAT polymorphism and diverse clinical manifestations in methamphetamine abusers. | Liu HC et al. | β | 2004 | β |
| Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. | Contin M et al. | β | 2004 | β |
| Eating disorders with binge-eating behaviour are associated with the s allele of the 3'-UTR VNTR polymorphism of the dopamine transporter gene. | Shinohara M et al. | β | 2004 | β |
| Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. | van der Wee NJ et al. | β | 2004 | β |
| Genetics of tobacco use. | Maserejian NN et al. | β | 2004 | β |
| Hostility differentiates the brain metabolic effects of nicotine. | Fallon JH et al. | β | 2004 | β |
| Influence of methylphenidate on eating in obese men. | Leddy JJ et al. | β | 2004 | β |
| Interacting effects of genetic predisposition and depression on adolescent smoking progression. | Audrain-McGovern J et al. | β | 2004 | β |
| Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. | Heinz A et al. | β | 2004 | β |
| Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. | Roman T et al. | β | 2004 | β |
| Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. | Epstein LH et al. | β | 2004 | β |
| Animal models of attention-deficit hyperactivity disorder. | Davids E et al. | β | 2003 | β |
| Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. | Kirley A et al. | β | 2003 | β |
| Dopamine genes and attention-deficit hyperactivity disorder: a review. | DiMaio S et al. | β | 2003 | β |
| Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. | Lerman C et al. | β | 2003 | β |
| Elucidating the role of genetic factors in smoking behavior and nicotine dependence. | Lerman C et al. | β | 2003 | β |
| Functional effects of the DAT1 polymorphism on EEG measures in ADHD. | Loo SK et al. | β | 2003 | β |
| Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. | Anchordoquy HC et al. | β | 2003 | β |
| Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. | Lynch DR et al. | β | 2003 | β |
| L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. | Kaiser R et al. | β | 2003 | β |
| Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. | Hawi Z et al. | β | 2003 | β |
| Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. | Ujike H et al. | β | 2003 | β |
| Pharmacogenomics of psychiatric drug treatment. | Pickar D | β | 2003 | β |
| Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. | Greenwood TA et al. | β | 2003 | β |
| Recent genetic advances in ADHD and diagnostic and therapeutic prospects. | Hawi Z et al. | β | 2003 | β |
| Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. | Kahn RS et al. | β | 2003 | β |
| Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. | Hall FS et al. | β | 2003 | β |
| The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. | Gorwood P et al. | β | 2003 | β |
| The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. | Krause KH et al. | β | 2003 | β |
| Association between the dopamine transporter gene and posttraumatic stress disorder. | Segman RH et al. | β | 2002 | β |
| Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. | Goudreau JL et al. | β | 2002 | β |
| Cocaine, reward, movement and monoamine transporters. | Uhl GR et al. | β | 2002 | β |
| Dopamine transporter genotype as a risk factor for obesity in African-American smokers. | Epstein LH et al. | β | 2002 | β |
| Dopamine transporter polymorphism associated with externalizing behavior problems in children. | Young SE et al. | β | 2002 | β |
| Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. | Mill J et al. | β | 2002 | β |
| Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. | Hahn MK et al. | β | 2002 | β |
| Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. | Miller GM et al. | β | 2002 | β |
| Segmental linkage disequilibrium within the dopamine transporter gene. | Greenwood TA et al. | β | 2002 | β |
| The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). | Madras BK et al. | β | 2002 | β |
| Association of a polymorphism of the dopamine transporter gene with externalizing behavior problems and associated temperament traits: a longitudinal study from infancy to the mid-teens. | Jorm AF et al. | β | 2001 | β |
| Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. | Curran S et al. | β | 2001 | β |
| Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. | Miller GM et al. | β | 2001 | β |
| Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. | Greenwood TA et al. | β | 2001 | β |
| Imaging neurochemical endophenotypes: promises and pitfalls. | Martinez D et al. | β | 2001 | β |
| Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography. | Tupala E et al. | β | 2001 | β |
| Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. | Fukuzako H | β | 2001 | β |
| Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. | Miller GM et al. | β | 2001 | β |
| The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. | Michelhaugh SK et al. | β | 2001 | β |
| The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. | Bannon MJ et al. | β | 2001 | β |
| The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. | Fuke S et al. | β | 2001 | β |
| Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. | Rowe DC et al. | β | 2001 | β |
| Effects of dextroamphetamine on cognitive performance and cortical activation. | Mattay VS et al. | β | 2000 | β |
| Genotype effects on neurodegeneration and neuroadaptation in monoaminergic neurotransmitter systems. | Heinz A et al. | β | 2000 | β |
| Neuropharmacological studies with SPECT in neuropsychiatric disorders. | Heinz A et al. | β | 2000 | β |
| Prediction of dopamine transporter binding availability by genotype: a preliminary report. | Jacobsen LK et al. | β | 2000 | β |